Mohamed Abazeed

Citado por

	Total	Desde 2019
Citas	2733	1819
Índice h	26	24
Índice i10	36	29

420

210

105

315

20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202410 25 49 53 45 72 48 36 33 50 31 29 32 31 28 50 108 171 192 309 365 418 385 145

Acceso público

Ver todo

37 artículos

3 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Omar Y. Mian, M.D., Ph.D.Translational Hematology and Oncology Research, Cleveland ClinicDirección de correo verificada de ccf.org
Roberta S. FullerProfessor Emerita of Biological Chemistry, University of MichiganDirección de correo verificada de umich.edu
babal jhaCleveland ClinicDirección de correo verificada de ccf.org
Jacob G. Scott (he/him)Associate Professor and Staff Physician-Scientist, Translational Hematology and Oncology ResearchDirección de correo verificada de ccf.org
PABLO TAMAYOProfessor, Division of Genomics and Precision Medicine, UC San DiegoDirección de correo verificada de ucsd.edu
Gabriel NuñezPaul de Kruif Professor of Pathology, University of Michigan Medical SchoolDirección de correo verificada de umich.edu
Nathan PennellCleveland ClinicDirección de correo verificada de ccf.org
Andrew DhawanAssociate Staff Neuro-Oncologist and Physician-Scientist, Cleveland ClinicDirección de correo verificada de ccf.org
Andriy MarusykMoffitt Cancer CenterDirección de correo verificada de moffitt.org
Dr. Sunil K. UpadhyayThermo Fisher ScientificDirección de correo verificada de thermofisher.com
Zhenfei LiShanghai institute of biochemistry and cell biology, CASDirección de correo verificada de sibcb.ac.cn
Jianneng LiUniversity of Notre DameDirección de correo verificada de nd.edu
Mohammad AlyamaniUniversity of Miami; Sylvester Comprehensive Cancer CenterDirección de correo verificada de miami.edu
Nima SharifiUniversity of Miami Miller School of MedicineDirección de correo verificada de miami.edu
Dmitriy SonkinNCIDirección de correo verificada de nih.gov
Chad CreightonProfessor of Medicine, Baylor College of MedicineDirección de correo verificada de bcm.edu
Daniel NicholEvolutionary Genomics and Modelling, Institute of Cancer Research, UKDirección de correo verificada de icr.ac.uk
Austin OleskiePhD candidate, Vanderbilt UniversityDirección de correo verificada de vanderbilt.edu
Georgios SkiniotisProfessor of Molecular and Cellular Physiology and of Structural BiologyDirección de correo verificada de stanford.edu
Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health NetworkDirección de correo verificada de uhnresearch.ca

Seguir

Mohamed Abazeed

Associate Professor, Northwestern University

Dirección de correo verificada de northwestern.edu

cancer genomics treatment resistance tumor evolution artificial intelligence personalized treatments


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κB signaling pathway PC Lucas, M Yonezumi, N Inohara, LM McAllister-Lucas, ME Abazeed, ... Journal of Biological Chemistry 276 (22), 19012-19019, 2001	542	2001
Therapy-induced senescence: opportunities to improve anticancer therapy PG Prasanna, DE Citrin, J Hildesheim, MM Ahmed, S Venkatachalam, ... JNCI: Journal of the National Cancer Institute 113 (10), 1285-1298, 2021	187	2021
An image-based deep learning framework for individualising radiotherapy dose: a retrospective analysis of outcome prediction B Lou, S Doken, T Zhuang, D Wingerter, M Gidwani, N Mistry, L Ladic, ... The Lancet Digital Health 1 (3), e136-e147, 2019	180	2019
Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy Z Li, M Alyamani, J Li, K Rogacki, M Abazeed, SK Upadhyay, SP Balk, ... Nature 533 (7604), 547-551, 2016	167	2016
A genetic basis for the variation in the vulnerability of cancer to DNA damage BD Yard, DJ Adams, EK Chie, P Tamayo, JS Battaglia, P Gopal, ... Nature communications 7 (1), 11428, 2016	164	2016
Integrative radiogenomic profiling of squamous cell lung cancer ME Abazeed, DJ Adams, KE Hurov, P Tamayo, CJ Creighton, D Sonkin, ... Cancer research 73 (20), 6289-6298, 2013	133	2013
Characterizing genomic alterations in cancer by complementary functional associations JW Kim, OB Botvinnik, O Abudayyeh, C Birger, J Rosenbluh, Y Shrestha, ... Nature biotechnology 34 (5), 539-546, 2016	101	2016
A histologic basis for the efficacy of SBRT to the lung NM Woody, KL Stephans, M Andrews, T Zhuang, P Gopal, P Xia, ... Journal of Thoracic Oncology 12 (3), 510-519, 2017	97	2017
Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer A Dhawan, D Nichol, F Kinose, ME Abazeed, A Marusyk, EB Haura, ... Scientific reports 7 (1), 1232, 2017	92	2017
The Vps13p–Cdc31p complex is directly required for TGN late endosome transport and TGN homotypic fusion M De, AN Oleskie, M Ayyash, S Dutta, L Mancour, ME Abazeed, EJ Brace, ... Journal of Cell Biology 216 (2), 425-439, 2017	91	2017
The implications of genetic testing on radiation therapy decisions: a guide for radiation oncologists C Bergom, CM West, DS Higginson, ME Abazeed, B Arun, SM Bentzen, ... International Journal of Radiation Oncology* Biology* Physics 105 (4), 698-712, 2019	86	2019
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures R Vander Velde, N Yoon, V Marusyk, A Durmaz, A Dhawan, ... Nature communications 11 (1), 2393, 2020	84	2020
Consequences of mutant TET2 on clonality and subclonal hierarchy CM Hirsch, A Nazha, K Kneen, ME Abazeed, M Meggendorfer, ... Leukemia 32 (8), 1751-1761, 2018	64	2018
Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) identifies prognostic biomarkers and DLL3 as a relevant therapeutic target VS Koshkin, JA Garcia, J Reynolds, P Elson, C Magi-Galluzzi, ... Clinical Cancer Research 25 (1), 210-221, 2019	56	2019
Molecular characteristics of biliary tract cancer DPS Sohal, S Shrotriya, M Abazeed, M Cruise, A Khorana Critical Reviews in Oncology/Hematology 107, 111-118, 2016	53	2016
A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms Y Guan, AD Tiwari, JG Phillips, M Hasipek, DR Grabowski, S Pagliuca, ... Blood cancer discovery 2 (2), 146-161, 2021	45	2021
Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia H Awada, Y Nagata, A Goyal, MF Asad, B Patel, CM Hirsch, ... Blood advances 3 (3), 339-349, 2019	40	2019
Cell-free transport from the trans-golgi network to late endosome requires factors involved in formation and consumption of clathrin-coated vesicles ME Abazeed, JM Blanchette, RS Fuller Journal of Biological Chemistry 280 (6), 4442-4450, 2005	38	2005
Radiotherapy in the era of precision medicine B Yard, EK Chie, DJ Adams, C Peacock, ME Abazeed Seminars in radiation oncology 25 (4), 227-236, 2015	37	2015
Inhibition of protein synthesis by didemnins: Cell potency and SAR D Ahuja, A Geiger, JM Ramanjulu, MD Vera, B SirDeshpande, ... Journal of medicinal chemistry 43 (22), 4212-4218, 2000	37	2000

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores